Local Drug Delivery to Treat Chronic Periodontitis

Authors

  • Mamoora Arslaan
  • Nasim Karim
  • Wahab Baksh Kadri
  • Shama Asghar

DOI:

https://doi.org/10.51985/JBUMDC2019123

Abstract

Periodontal disease is a chronic inflammatory disease of periodontium characterized by increased pocket depth, clinical
attachment loss, sulcular bleeding, and bone loss. Bacterial plaque bio-film stimulates host derived enzymes and cytokines
like TNF , IL-1 and matrix metalloproteases that lead to destruction of periodontium, collagenolytic activity, decreased
bone mineral density, intra-bony defects and ultimately bone loss. Chronic periodontitis is managed by conventional and
systemic approach, where conventional therapy comprises of scaling and root planning. Mechanical debridement of plaque
also requires an adjunct to eradicate the root cause of progressing disease. Hence, worldwide paradigm has shifted towards
novel therapies; therefore, local delivery of drug is now preferred due to direct access to target sites with considerably less
adverse effects and a better approach to deal with chronic periodontitis. The nano-particle technology to treat periodontitis
is still an emerging and promising strategy for the management of disease with the provision of minimal dose, less invasive
procedure and clinical efficacy.

References

Srinath,S. Management of periodontal disease with doxycycline: An update. International Journal of Pharmaceutical and Clinical Research. 2015;7(4): 252-55

S, R, RD, SH, SR, Khan NAB. Prevalence of chronic periodontitis in an obese population: A preliminary study.BMC Oral Health.2015;15:114. DOI 10.1186/s12903-015-0098-3

Al Qahtani NA, Joseph B, Deepthi A, Vijayakumari BK. Prevalence of chronic periodontitis and its risk determinants among female patients in the Aseer Region of KSA. Journal of Taibah University Medical Sciences.2017;12(3): 241-48

Altamash M, Klinge B, Engström P.E. Periodontal treatment and HbA1c levels in subjects with diabetes mellitus. Journal of Oral Rehabilitation 2016; 43:31-8.

SalwaMemon ,FarzanaMemon , Hassan Shahid , Diya Ram Khatri , Shoukat Ali Memon. Prevalence of Gingivitis in School Children at Different Government Schools of District Hyderabad. JBUMDC. 2016; 6(4): 236-40

Jiang N,Guo W, Chen M,Zheng Y, Zhou J, Kim SG etal. Periodontal ligament and alveolar bone in health andadaptation: tooth movement. Front Oral Biology. 2016;18:1–8.

Katancik JA, Kumarswamy A, BranchMays G, Califano JV. Infections of the Periodontal Apparatus.Head, Neck, and Orofacial Infections,2016;189–202. doi:10.1016/b978-0-323- 28945-0.00011

Jamal M, Tasneem U, Hussain T, Andleeb,S. Bacterial Biofilm: Its Composition, Formation and Role in Human Infections. Journal of Microbiology and Biotechnology.2015. e- ISSN:2320-3528 p-ISSN:2347

ColomboAPV, MagalhaesCB, HartenbachFARR, DoSouto, RM,daSilvaBoghossianCM. Periodontal disease associated biofilm: A reservoir for pathogens of medical importance . Microbial Pathogenesis.2015;94 :27-34

ZS, RH,LT, HF, DA, HA et al. Chronic periodontitis case definitions and confounders in periodontal research: A Systematic Assessment. HindawiBioMed Research International.2018. Article ID 4578782,

A, S, SAO, J, A. The association between oral hygiene and periodontitis: A systematic review and meta-analysis. International Dental Journal.2017;67(6):332-43.

SpasovskiS, BelazelkoskaZ, PopovskaM, StojanovskaAA, RadojkovaNikolovskaV, MuratovskaI et al. Clinical therapeutic effects of the application of doxycycline in the treatment of periodontal disease. Macedonian Journal of Medical Sciences. 2017;4(1):152-57.

Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. International Journal of Health Sciences.2017;11( 2): 72-80

Attia MA, Mohamed AD, Alharthi AS, Almutawwif MA, Hamad AA, Alhuthali WM. Severity of chronic periodontitis associated with two major risk factors of periodontal disease in Makkah city. J Dent Oral Care.2017; 3(1): 9- 15. DOI: 10.15436/2379-1705.17.1316

Tanwar J, Hungund SA, Dodani K. Nonsurgical periodontal therapy: A review. Journal of Oral Research and Review.2016;8: 39-44.

DeekshaJ, TarunG, AmitK, Goyal,Goutam R .Advanced drug delivery approaches against periodontitis. Drug Delivery. 2016; 23(2): 363-77, DOI:10.3109/10717544.2014.935531

Shivani P, Jaimini G, Harita N, Lakshmi P, Pranav S. Advanced Local Drug Delivery Approaches for Periodontitis: A Strategic Intervention. A Journal of PharmaceuticalScience.2017;9(1): 4-11

PooyaDavoodi, Lai YengLee ,QingxingXu , Vishnu Sunil , Yajuan Sun , SiowlingSoh, Chi-HwaWang. Drug delivery systems for programmed and on-demand release. Adv. Drug Delivery Reviews. 2018, 1-35. doi.org/10.1016/ j.addr. 2018.07.002

MinghanChi ,Manlin Qi , Lan A , Ping Wang , Michael DW, Mary A M . Novel Bioactive and Therapeutic Dental Polymeric Materials to Inhibit Periodontal Pathogens and Biofilms. Int. J. Mol. Sci. 2019; 20: 278; 1-29 doi:10.3390/ijms20020278

Abeer AK, Doaa AEI, GehanSK, Ragwa MF . Thiolated alginate-based multiple layer mucoadhesive films of metformin for intra-pocket local delivery: in vitro characterization and clinical assessment.Drug Development and Industrial Pharmacy. 2017;43(1):120-31.

Sah AK, Dewangan M, Suresh PK. Potential of chitosan- based carrier for periodontal drug delivery, Colloids and Surfaces B Biointerfaces.2019;178:185-98 doi.org/10.1016/ j.colsurfb.2019.02.04

LiviaN,Alfredo D R, Vincenza DG, VincenzoG, Giovanna D. A New Controlled-Release Material Containing Metronidazoleand Doxycycline for the Treatment of Periodontal and Peri-Implant Diseases: Formulation and In Vitro Testing International Journal of Dentistry.2019;1- 10Article ID 9374607. doi.org/10.1155/2019/9374607

Urooj A K, Uzma P, Anshul G, GauravKJ ,Farhan JA. Periodontitis: Progression And Treatment Approaches: A Review. Ejbps. 2018;5(6): 153-69.

Qinyuan C, Yang J, Xinjun Y. Hydrogels for Biomedical Applications: Their Characteristics and the Mechanisms behind Them. Gels. 2017;3(6):1-15 doi:10.3390/gels3010006

KerongY,QingH,BingpengC,YuhaoZ,KesongZ,Qiang L et al. Antimicrobial hydrogels: promising materials for medical application. International Journal of Nanomedicine. 2017;3:2217-30

Tarek A, Bader M. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole. International Journal of Nanomedicine 2017:12(5):1863-75

Mihaela V G, Mircea H, DumitruL , Cristina E DP. Flow and Thixotropic Parameters for Rheologica Characterization of Hydrogels. Molecules.2016;21:786:1-17doi:10.3390/ molecules21060786

Huberth ARJ, Camila FS, Fernanda LS, Ludiele GM, PâmellaCD, Denildo DM. Local Drug Delivery Systems in the Treatmentof Periodontitis: A Literature Review. Journal of the International Academy of Periodontology.2015.17(3): 82–90

Joshi D, Garg T, GoyalAK ,RathG.Advanced drug delivery approaches againstperiodontitis.DrugDelivery.2016;23:2,363- 77. doi:10.3109/10717544.2014.935531

GiulianoE, Paolino D, FrestaM ,CoscoD. Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview. Pharmaceutics. 2018; 10(3):159-83doi:10.3390/ pharmaceutics 10030159

JianyuLi ,David JM. Designing hydrogels for controlled drug delivery. Nat Rev Mater. 2016; 1(12):4736-45. doi:10.1038/ natrevmats.2016.71.

Mil é naL ,Nikolett K S, Vince A, András J ózsefLaki, IstvánAntal. Microparticles, Microspheres, and Microcapsules forAdvanced Drug Delivery. Sci. Pharm. 2019; 87( 20):1- 31.doi:10.3390/scipharm8703002

Zeeshan S, Shariq N, Zohaib K, Vivek V, HaroonR,Michael

G. Biodegradable Materials for Bone Repair and TissueEngineering Applications.Materials.2015; 8: 5744-94; doi:10.3390/ma8095273

NourAlhusein ,Ian SB, Michael LB, Albert B , Paul ADB . ElectrospunZein/PCL Fibrous Matrices Release Tetracycline in a Controlled Manner, Killing Staphylococcus aureus Both in Biofilms and Ex Vivo on Pig Skin, and are Compatible with Human Skin Cells. Pharm Res. 2016; 33:237–46. DOI 10.1007/s11095-015-1782-3

Dileep P, Kurian IG, PradeepAR. Comparative evaluation of subgingivally delivered 1.2% rosuvastatinand 1% metformin gelin treatment of intrabony defects in chronic periodontitis: A randomized controlled clinical trial. Journal of Periodontology.2018;89(11):1318-25.doi:10.1002/jper.17- 0434

Vijay M, Kuldeep KB, Asit V, Nishika Y, Sourav T, Kalvatala S et al. Solid lipid nanoparticles: emerging colloidal nanodrug delivery systems. Pharmaceutics.2018; 10(4):191-212. doi:10.3390/pharmaceutics10040191

H Lu, J Wang, M Stoller, T Wang, Y Bao, HHao. An Overview of Nanomaterials for Water and Wastewater Treatment. Advances in Materials Science and Engineering . 2016.1- 10.doi.org/10.1155/2016/4964828

Jean PD, Bérénice HH, Anne LF, Laurence N, Frédéric N. Self-Assembly of Bilayer Vesicles Made of Saturated Long Chain Fatty Acids. Langmuir, American Chemical Society.2016,32(2):401-10.

Alfonso TC, Mario FC, Jaime SS ,Ernesto CN, Rafael J, Pavel A et al. Liposomes Loaded with Cisplatin and MagneticNanoparticles:PhysicochemicalCharacterization,P harmacokinetics, and In-Vitro Efficacy.Molecules.2018; 23(9): 2272-88. doi:10.3390/molecules23092272

Rogalski JJ, Bastiaansen C W M ,Peijs T. Rotary jet spinning review – a potential high yield future for polymer nanofibers, Nanocomposites.2017;3(4):97-121, DOI: 10.1080/20550324. 2017.1393919

Muhammad Z, Shariq N, Zohaib K, Masoud V, Sana Z,Bilal N et al. Potential of ElectrospunNanofibersforBiomedical and Dental Applications.Materials.2016; 9: 73-94.

.Divya P , Maria TPA, Joshua DE, Malgorzata MK, Richard LG , Marco CB. Triple Antibiotic Polymer Nanofibers for Intracanal Drug Delivery: Effects on Dual Species Biofilm and Cell Function. J Endod. 2016;42(10):106-12

Marco CB, Rodrigo AA, Aaron W, Krzysztof K, Karen SG, Richard LG Biodegradablenanofibrous drug delivery systems: Effects of metronidazole and ciprofloxacin on periodontopathogens and commensal oral bacteria. ClinOralInvestig. 2014 ; 18(9): 2151–58.

Sara A ,Jaideep M , Geetha A. Minocycline Ointment as a Local Drug Delivery in the Treatment of Generalized Chronic Periodontitis - A Clinical Study. Journal of Clinical and Diagnostic Research. 2016 ; 10(6): ZC15-ZC1

DeekshaJ, TarunG, AmitK, Goyal,Goutam R .Advanced drug delivery approaches againstperiodontitis. Drug Delivery. 2016; 23(2): 363-77,DOI:10.3109/10717544.2014.93553

Xi C, Guofeng W, Zhihong F, Yan D, Wei Z, Bei L, Shizhu B, Yimin Z. Advancedbiomaterials and their potential applications in the treatment of periodontal disease. Informa Healthcare USA. 2015;28:1829-38.DOI: 10.3109/07388551

.2015.1035693

Downloads

Published

2021-03-18

How to Cite

Arslaan, M. ., Karim, N. ., Kadri, W. B. ., & Asghar, S. . (2021). Local Drug Delivery to Treat Chronic Periodontitis. Journal of Bahria University Medical and Dental College, 10(2), 158–162. https://doi.org/10.51985/JBUMDC2019123

Issue

Section

Review Article

Most read articles by the same author(s)

1 2 3 4 > >>